Reducing the impact and £2bn cost of adverse drug reactions
By 
Alison Cave2024-09-24T11:00:00
Alison Cave writes how new technology continues to drive the Yellow Card scheme forward, serving to improve user experience and streamline reporting, in order to enhance patient safety
Register with hsj.co.uk to read the rest of this article
Critical stories remain free for registered users
Certain articles and Insight pieces remain paying-subscriber only content
As a registered user you will get access to:
- Daily News: an essential email round-up of all the latest news, comment and best practice
- Breaking news headlines delivered directly to your inbox
- Limited access to hsj.co.uk
Already registered to HSJ? Sign in now